Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021

SELL
$216.38 - $257.67 $4.78 Million - $5.69 Million
-22,086 Closed
0 $0
Q3 2020

Oct 13, 2020

BUY
$234.65 - $260.95 $125,068 - $139,086
533 Added 2.47%
22,086 $5.29 Million
Q2 2020

Aug 05, 2020

SELL
$197.81 - $242.74 $7,912 - $9,709
-40 Reduced 0.19%
21,553 $5.25 Million
Q1 2020

May 06, 2020

SELL
$182.24 - $241.7 $106,428 - $141,152
-584 Reduced 2.63%
21,593 $4.38 Million
Q4 2019

Feb 05, 2020

SELL
$189.21 - $243.2 $12,298 - $15,808
-65 Reduced 0.29%
22,177 $4.92 Million
Q3 2019

Oct 22, 2019

BUY
$174.11 - $208.62 $41,786 - $50,068
240 Added 1.09%
22,242 $4.51 Million
Q2 2019

Aug 08, 2019

BUY
$166.7 - $195.41 $492,098 - $576,850
2,952 Added 15.5%
22,002 $3.83 Million
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $12,299 - $13,863
-68 Reduced 0.36%
19,050 $3.62 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $3.41 Million - $3.98 Million
19,118 New
19,118 $3.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Miramar Capital, LLC Portfolio

Follow Miramar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miramar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miramar Capital, LLC with notifications on news.